Health and Recovery Plan (HARP)
Value Based Payment Quality Measure Set
Measurement Year 2021
- Measure Set is also available in Portable Document Format (PDF)
February 11, 2021 NYS Medicaid Value Based Payment
INTRODUCTION
The Measurement Year (MY) 2021 Health and Recovery Plan (HARP) Quality Measure Set was created in collaboration with the HARP Clinical Advisory Group (CAG), as well as the New York State (NYS) Value Based Payment (VBP) Workgroup. The goal of this measure set is to align with measures sets put forth in the Delivery System Reform Incentive Payment (DSRIP) Program, for the Quality Assurance Reporting Requirements (QARR), and the Merit-based Incentive Payment System (MIPS), where applicable. The HARP measure set was designed to encourage providers to meet high standards of patient-centered clinical care and coordination across multiple care settings for the HARP population.
MEASURE SELECTION AND FEASIBILITY
During the spring and summer of 2020, the HARP CAG reconvened and made recommendations to the State on quality measures, data collection, data reporting, and support required for providers to be successful in a VBP environment.
Beginning in June of 2017, the State initiated regular meetings of the VBP Measure Support Task Force. The goal of the Task Force is to make recommendations to the State to support and inform during the Annual Measure Review Cycle. Members of the Task Force include professionals from various Managed Care Organizations (MCOs), Clinical Subject Matter Experts, and State Agencies, along with other professionals who have experience in quality measurement and health information technology. The Task Force provides feedback to the Department of Health (DOH) on quality measure feasibility, reporting, and calculation.
Upon receiving the CAG recommendations and Task Force feedback, the State defined a final list of measures for inclusion for MY2021. For MY2021, two measures have been removed, two measures specifications have changed, and one measure has been added as a replacement, culminating in a total of thirty-seven Category 1 and 2 HARP Quality Measures.
MEASURE CLASSIFICATION
Each measure has been designated by the State as Category 1, 2, or 3 with associated recommendations for implementation and testing for future use in VBP Arrangements. The measures below are classified by category based on an assessment of reliability, validity, and feasibility, and according to suggested method of use (either Pay for Reporting (P4R) or Pay for Performance (P4P)).
Categorizing and Prioritizing Quality Measures
CATEGORY 1
Approved quality measures that are deemed to be clinically relevant, reliable, valid, and feasible.
CATEGORY 2
Measures that are clinically relevant, valid, and reliable, but where the feasibility could be problematic. These measures were investigated during the 2017 & 2020 pilot programs.
CATEGORY 3
Measures that are insufficiently relevant, valid, reliable and/or feasible.
Category 1
Category 1 quality measures as identified by the CAGs and accepted and deemed reportable by the State are to be reported by VBP Contractors to the MCOs. These measures are also intended to be used to determine the amount of shared savings for which VBP contractors are eligible.1 At least one Category 1 P4P measure must be included in a VBP contract.
The State classified each Category 1 measure as either P4P or P4R:
- P4P measures are intended to be used in the determination of shared savings amounts for which VBP Contractors are eligible. Measures can be included in both the determination of the target budget and in the calculation of shared savings for VBP Contractors.
- P4R measures are intended to be used by the Managed Care Organizations (MCOs) to incentivize VBP Contractors for reporting data to monitor quality of care delivered to members under the VBP contract. Incentives for reporting will be based on timeliness, accuracy, and completeness of data. Measures can be reclassified from P4R to P4P through annual CAG and State review or as determined by the MCO and VBP Contractor.
Not all Category 1 measures will be reportable for the measurement year, as reporting on some of these measures will be phased in over the next few years. Please refer to the Value Based Payment Reporting Requirements Technical Specifications Manual (MY2021) for details as to which measures must be reported for the measurement year. This manual will be updated annually each fall, in line with the release of the final VBP measure set for the subsequent year.
Categories 2 and 3
Category 2 measures have been accepted by the State based on agreement of clinical importance, validity, and reliability, but flagged as presenting concerns regarding implementation feasibility. Some of these measures have been further investigated in the VBP Pilots. The State has discussed measure testing approaches, data collection, and reporting requirements as a part of the Measure Support Task Force.
Measures designated as Category 3 were identified as unfeasible at this time or as presenting additional concerns including accuracy or reliability when applied to the attributed member population for an arrangement, therefore Category 3 measures are not included in the measure set.
MY2021 BEHAVIORAL HEALTH/HARP QUALITY MEASURE SET
The measures and State-determined classifications provided on the following pages are recommendations for MY2021. Note that measure classification is a State recommendation and implementation is to be determined between the MCO and VBP Contractor.
Measure sets and classifications are considered dynamic and will be reviewed annually. Updates will include measure additions, deletions, recategorizations, and/or reclassifications from P4R to P4P or vice versa, based on experience with measure implementation in the prior year. During 2021, the CAGs and the VBP Workgroup will re-evaluate measures and provide recommendations for MY 2022. Please see Appendix A for a full list of these changes.
Note: Additional changes may have been made to the names for some of the measures presented below to ensure alignment with the naming conventions used by the official measure steward. There have not been any changes to the measure specifications associated with these name changes.
Category 1
The table below displays the Category 1 MY2021 HARP Quality Measure Set, arranged alphabetically, and includes measure title, measure steward, the National Quality Forum (NQF) number and/or other measure identifier (where applicable), and State-recommended classification for measure use. The measure set is redlined to highlight changes made between MY2020 and MY2021, please refer to the key at the end of this table for an explanation of redlined formatting.
| Measure | Measure Steward | Measure Identifier | Classification |
|---|---|---|---|
| Adherence to Antipsychotic Medications for Individuals with Schizophrenia | Centers for Medicare & Medicaid Services (CMS) | NQF 1879 | P4P |
| Asthma Medication Ratio | National Committee for Quality Assurance (NCQA) | NQF 1800 | P4P |
| Breast Cancer Screening | NCQA | NQF 2372 | P4P |
| Cervical Cancer Screening | NCQA | NQF 0032 | P4P |
| Chlamydia Screening in Women | NCQA | NQF 0033 | P4P |
| Colorectal Cancer Screening | NCQA | NQF 0034 | P4P |
| Completion of Home and Community Based Services Annual Needs Assessment | NYS | P4P | |
| Comprehensive Diabetes Care: Eye Exam (retinal) Performed | NCQA | NQF 0055 | P4P |
| Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Poor Control (>9.0%) | NCQA | NQF 0059 | P4P |
| Controlling High Blood Pressure | NCQA | NQF 0018 | P4P |
| Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications | NCQA | NQF 1932 | P4P |
| Employed, Seeking Employment or Enrolled in a Formal Education Program | NYS | - | P4R |
| Follow-Up After Emergency Department Visit for Alcohol and Other Drug Dependence | NCQA | NQF 2605 | P4P |
| Follow-Up After Emergency Department Visit for Mental Illness | NCQA | NQF 2605 | P4P |
| Follow-Up After High-Intensity Care for Substance Use Disorder | NCQA | P4P | |
| Follow-Up After Hospitalization for Mental Illness** | NCQA | NQF 0576 | P4P |
| Initiation of Pharmacotherapy upon New Episode of Opioid Dependence | NYS | - | P4P |
| Kidney Health Evaluation for Patients With Diabetes (KED)^^ | NCQA | ||
| No Arrests in the Past Year | NYS | - | P4R |
| Percentage of Members Enrolled in a Health Home | NYS | - | P4R |
| Pharmacotherapy for Opioid Use Disorder | NCQA | NQF 3175 | P4P |
| Potentially Preventable Mental Health Related Readmission Rate 30 Days | NYS | - | P4P |
| Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | CMS | NQF 0421 | P4R |
| Preventive Care and Screening: Influenza Immunization (AMA PCPI) | American Medical Association Physician Consortium for Performance Improvement | NQF 0041 | P4R |
| Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | AMA PCPI | NQF 0028 | P4R |
| Stable Housing Status | NYS | - | P4R |
| Statin Therapy for Patients with Cardiovascular Disease** | NCQA | - | P4R |
| Use of Pharmacotherapy for Alcohol Abuse or Dependence | NYS | - | P4R |
| Use of Spirometry Testing in the Assessment and Diagnosis of COPD | NCQA | NQF 0577 | P4R |
* Measure removed from HEDIS 2021 Measure Set
** Measure specifications revised by NCQA for 2021 HEDIS Measure set
^^ Measure replaced by NCQA/HEDIS measure
^^ Replacement HEDIS measure – first year measure
Category 2
The table below displays the Category 2 MY2021 Behavioral Health/HARP Quality Measure Set and includes measure title, measure steward, and the NQF number and/or other measure identifier (where applicable). All Category 2 measures are classified as P4R in MY2021. There are no changes in CAT2 measures between MY2020 and MY2021.
| Measure | Measure Steward | Measure Identifier |
|---|---|---|
| Adherence to Mood Stabilizers for Individuals with Bipolar I Disorder | CMS | NQF 1880 |
| Asthma Action Plan | American Academy of Allergy, Asthma & Immunology (AAAAI) | - |
| Asthma: Assessment of Asthma Control – Ambulatory Care Setting | AAAAI | - |
| Asthma: Spirometry Evaluation | AAAAI | - |
| Continuing Engagement in Treatment Alcohol and Other Drug Dependence | NYS | - |
| Mental Health Engagement in Care 30 Days | NYS | - |
| Percentage of HARP Enrolled Members Who Received Personalized Recovery Oriented Services (PROS) or Home and Community Based Services (HCBS) | NYS | - |
| Use of Opioid Dependence Pharmacotherapy | NYS | - |
Appendix A
The table below identifies the changes to the Category 1 and Category 2 measures for the MY2021 HARP Quality Measure Set.
Category 1 Measure Changes from 2020 to 2021
| Measure Name | Change | Rationale for Change |
|---|---|---|
| Comprehensive Diabetes Care: Medical Attention for Nephropathy | Removed | Measure removed from HEDIS 2021 Measure Set |
| Follow-Up After Hospitalization for Mental Illness | Changed | Measure specifications changed by NCQA for 2021 Measure set |
| Kidney Health Evaluation for Patients With Diabetes (KED) | Added | Replacement HEDIS measure - first year measure |
| Medication Management for People with Asthma | Removed | Measure removed from HEDIS 2021 Measure Set |
| Statin Therapy for Patients with Cardiovascular Disease | Changed | Measure specifications changed by NCQA for 2021 Measure set |
__________________________________________________________
1. New York State Department of Health, Medicaid Redesign Team, A Path Toward Value Based Payment: Annual Update, September 2020. (Link) 1
Follow Us